Literature DB >> 5040915

Autoregulation of growth hormone secretion in normal subjects.

T C Hagen, A M Lawrence, L Kirsteins.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5040915     DOI: 10.1016/0026-0495(72)90084-4

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


× No keyword cloud information.
  7 in total

1.  Prior endurance exercise attenuates growth hormone response to subsequent resistance exercise.

Authors:  Kazushige Goto; Masao Higashiyama; Naokata Ishii; Kaoru Takamatsu
Journal:  Eur J Appl Physiol       Date:  2005-02-16       Impact factor: 3.078

2.  Exogenous growth hormone inhibits growth hormone-releasing factor-induced growth hormone secretion in normal men.

Authors:  S M Rosenthal; J A Hulse; S L Kaplan; M M Grumbach
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

3.  Endocrine studies in anencephaly.

Authors:  A Hayek; S G Driscoll; J B Warshaw
Journal:  J Clin Invest       Date:  1973-07       Impact factor: 14.808

Review 4.  Amino acid supplementation and exercise performance. Analysis of the proposed ergogenic value.

Authors:  R B Kreider; V Miriel; E Bertun
Journal:  Sports Med       Date:  1993-09       Impact factor: 11.136

5.  Suppression of sleep-related prolactin secretion and enhancement of sleep-related growth hormone secretion.

Authors:  W B Mendelson; L S Jacobs; J D Reichman; E Othmer; P E Cryer; B Trivedi; W H Daughaday
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

6.  Plasma growth hormone responses to constant infusions of human pancreatic growth hormone releasing factor. Intermittent secretion or response attenuation.

Authors:  C B Webb; M L Vance; M O Thorner; G Perisutti; J Thominet; J Rivier; W Vale; L A Frohman
Journal:  J Clin Invest       Date:  1984-07       Impact factor: 14.808

7.  Exogenous growth hormone administration does not inhibit the growth hormone response to hexarelin in normal men.

Authors:  M Cappa; S Setzu; S Bernardini; D Carta; G Federici; A Grossi; S Loche
Journal:  J Endocrinol Invest       Date:  1995-11       Impact factor: 4.256

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.